The American Cancer Society’s (ACS) Diversity in Cancer Research (DICR) Program aims to increase diversity in the cancer research workforce by increasing the number of under-represented minorities in the biomedical field. The DICR Institutional Development Grant (IDG) is specifically designed to enhance the competitiveness of- faculty at minority-serving institutions (MSIs) when they apply for nationally competitive grant support as well as support faculty development and retention.
Diversity in science is critical because it invigorates problem-solving, drives innovation, and better equips the scientific community to address inequities that exist in cancer prevention, treatment, and care.
The lack of diversity within the scientific and medical workforce is a known issue.
Interactive Webinar to Learn More: Recorded and available upon request.
LOI Due Date: Tuesday, July 19, 2022 11:59 pm ET
Applications Open in proposalCENTRAL: Friday, July 22, 2022
Invitation-to-Apply Date: Monday, July 25, 2022
Full Application Due Date: Monday, Oct. 17, 2022
Award Notification: Nov. 2022
Grant Activation: Jan. 2023
Additional Questions: Email DiversityEDS@cancer.org
The National Science Foundation tracks workforce data every 2 years, and their reports reveal that certain racial and ethnic groups are under-represented at many career stages in the health-related sciences. Those populations include African American/Black, American Indian and Alaska Native, Hispanic/Latino, Native Hawaiian and other Pacific Islander groups. Collectively these groups are known as under-represented minorities (URM) in science.
There is a documented disparity in National Institutes of Health (NIH) grant application pools. Data from the NIH’s R01 grants in 2013 and 2018 showed that significantly fewer applications were submitted from certain racial and ethnic groups. Specifically:
This award is intended to increase capacity for cancer research career development at MSIs. For full applications, applicants will be required to outline their processes for recruitment, review, and selection for both the trainees and faculty candidates who will apply for and compete to receive support for research and career development awards. Funded institutions will create and administer a cancer research career development program.
Eligible institutions are 4-year degree granting institutions, including accredited colleges, universities, and medical schools within the United States (in accordance with ACS grant policies) who have received federal designation as an MSI.
MSIs are institutions of higher learning that serve minority populations, such as:
For more information see U.S.C. Title 20.
You ARE eligible to submit an LOI if you:
Note: If an institution has received DICR IDG funding, an investigator from the same institution will not be eligible to apply for this funding opportunity (only 1 DICR IDG can be awarded per institution).
Letter-of-Intent Requirements and Due Date: A letter-of-intent (LOI) process will be used for selecting investigators to submit a full application.
By July 19, 2022, the DICR IDG Administrative PI should submit the following via proposalCENTRAL:
Invitation-to-Apply Date: By July 25, 2022, invitation-to-apply decisions will be communicated to applicants via proposalCENTRAL. That correspondence will include a link to the grant application and instruction materials on proposalCENTRAL.
Selection of 3 DICR IDG grantee institutions will be based upon nationally competitive peer review conducted by the ACS according to established guidelines and policies.
A total budget of $2.631 M for a 4-year project period will support 26 trainees and junior faculty research. Sub-awards from this institutional block grant will then be awarded through the following ACS research grant mechanisms: Pilot Grants for new early career faculty, Clinician Scientist Development Grant (CSDG), Postdoctoral Fellowships (PF), and Master Scholars (MS) in Cancer Prevention and Control.
The DICR IDG should include the following sub-awards:
Overview: Small sub-award grant mechanism for new early-career faculty to test feasibility and collect preliminary data for a larger cancer research study.
Grant Term: 1 year
Number of Pilot Grants supported per institution: 16 overall (4 pilot grants/year for 4 years)
Total Budget: $480,000 ($30,000 per grant per year)
Overview: Provides protected time for early-career clinical scientists (Instructor or Assistant Professor) to be mentored and lead a cancer research study to aid their development as independent clinical scientists.
Eligibility: Licensed clinicians within the first 6 years of starting a full-time faculty appointment.
Grant Term: 4 years
Number of CSDGs supported per institution: 2
Total Budget: $1,200,000 ($600,000 per clinician scientist)
Overview: Provides mentored research experiences with the goal of becoming an independent investigator
Eligibility: A US citizen or permanent resident who has had a doctoral degree for LESS than 3 years
Grant Term: 3 years
Number of PFs supported per institution: 2
Total Budget: $351,000 ($175,500 per postdoctoral fellow)
Overview: Provides support for Master-level public health (MPH) students to complete a practicum related to cancer prevention and control.
Grant Term: 2 years
Number of MS grants supported per institution: 6 (3 MS cohorts a year for 2 years)
Total Budget: $300,000 ($50,000 per master scholar)
The Career Development Fund are discretionary funds to support career development.
Potential Ways to use these funds:
Fund term: 4 years
Total Budget: $300,000 ($75,000 a year)